Browsing: Health

(Reuters) -Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for more than $70 per share, Bloomberg News reported,…

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a…

By Kamal Choudhury and Amina Niasse (Reuters) -Hims and Hers Health beat Wall Street estimates for third-quarter revenue on Monday,…

Dec 19 (Reuters) – BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion,…

Dec 22 (Reuters) – The U.S. Food and Drug Administration approved Novo Nordisk’s weight-loss pill on Monday, giving ​the Danish…

By Maggie Fick and Dan Levine LONDON/SAN FRANCISCO, Jan 5 (Reuters) – Danish obesity drugmaker Novo Nordisk’s head of public…

SAN FRANCISCO, Jan 12 (Reuters) – Amgen’s research chief said the company is very confident about its experimental obesity drug…

HONG KONG, Jan 16 (Reuters) – China’s population policy is emerging as a key part of its economic strategy as…

Feb 4 (Reuters) – Drug developer Eikon ‍Therapeutics said on Wednesday it had raised $381.2 million in its U.S. ​initial…

Feb 10 (Reuters) – Zimmer Biomet on Tuesday beat Wall Street estimates for fourth-quarter profit and revenue as the company…